You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Lidocaine - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for lidocaine and what is the scope of patent protection?

Lidocaine is the generic ingredient in forty-five branded drugs marketed by Astrazeneca, Noven, Carlisle, Alembic, Alkem Labs Ltd, Amneal Pharms, Aurobindo Pharma Ltd, Belmora Llc, Cosette, Dr Reddys, Encube, Fougera Pharms Inc, Geneyork Pharms, Glenmark Pharms Ltd, Macleods Pharms Ltd, Quagen, Rising, Septodont Inc, Strides Pharma, Taro, Teva Pharms Usa, Vitruvias Therap, Actavis Labs Ut Inc, Amneal, Ibsa, Mylan Technologies, Nal Pharm, Noven Pharms Inc, Teikoku Pharma Usa, Scilex Pharms, Thea Pharma, Abbott, Abraxis Pharm, Afaxys, Am Regent, Aspiro, B Braun Medical Inc, Bel Mar, Dell Labs, Elkins Sinn, Epic Pharma Llc, Eugia Pharma, Fresenius Kabi Usa, Gd Searle Llc, Hospira, Huons, Intl Medication, Luitpold, Lyphomed, Mankind Pharma, Miles, Sintetica Us, Spectra Mdcl Devices, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Baxter Hlthcare, B Braun, Hikma, Pharmaton, Meridian Medcl Techn, Dentsply Pharm, Bionpharma, Sagent Pharms Inc, Sentiss, Watson Labs Inc, Rubicon, Wockhardt Bio Ag, Actavis Mid Atlantic, Chartwell Molecular, Pai Holdings Pharm, Kendall Il, Lannett Co Inc, Novitium Pharma, Paco, The J Molner, Powder Pharms, Pfizer, Teva Branded Pharm, Fougera Pharms, Padagis Us, Rhodes Pharms, Crescita Therap, and Galen Specialty, and is included in one hundred and sixty NDAs. There are fifteen patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Lidocaine has thirty-seven patent family members in eighteen countries.

There are twenty-nine drug master file entries for lidocaine. Forty-four suppliers are listed for this compound.

Drug Prices for lidocaine

See drug prices for lidocaine

Drug Sales Revenue Trends for lidocaine

See drug sales revenues for lidocaine

Recent Clinical Trials for lidocaine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sichuan Cancer Hospital and Research InstituteN/A
Jessyka LighthallPhase 3
Sawanpracharak hospitalN/A

See all lidocaine clinical trials

Pharmacology for lidocaine
Medical Subject Heading (MeSH) Categories for lidocaine
Paragraph IV (Patent) Challenges for LIDOCAINE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ZTLIDO Topical Patch lidocaine 1.80% 207962 1 2022-03-17
LIDODERM Topical Patch lidocaine 5% 020612 1 2009-11-13

US Patents and Regulatory Information for lidocaine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER lidocaine hydrochloride INJECTABLE;INJECTION 018461-002 Approved Prior to Jan 1, 1982 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE lidocaine hydrochloride INJECTABLE;INJECTION 084625-001 Approved Prior to Jan 1, 1982 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5% lidocaine hydrochloride INJECTABLE;SPINAL 083914-001 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Crescita Therap PLIAGLIS lidocaine; tetracaine CREAM;TOPICAL 021717-001 Jun 29, 2006 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Crescita Therap PLIAGLIS lidocaine; tetracaine CREAM;TOPICAL 021717-001 Jun 29, 2006 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Hikma LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride SOLUTION;ORAL 040014-001 Jul 10, 1995 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride SOLUTION;TOPICAL 088803-001 Apr 3, 1985 AT RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for lidocaine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teikoku Pharma Usa LIDODERM lidocaine PATCH;TOPICAL 020612-001 Mar 19, 1999 ⤷  Sign Up ⤷  Sign Up
Teikoku Pharma Usa LIDODERM lidocaine PATCH;TOPICAL 020612-001 Mar 19, 1999 ⤷  Sign Up ⤷  Sign Up
Noven DENTIPATCH lidocaine FILM, EXTENDED RELEASE;BUCCAL 020575-001 May 21, 1996 ⤷  Sign Up ⤷  Sign Up
Noven DENTIPATCH lidocaine PATCH;TOPICAL 020575-002 May 21, 1996 ⤷  Sign Up ⤷  Sign Up
Noven DENTIPATCH lidocaine PATCH;TOPICAL 020575-002 May 21, 1996 ⤷  Sign Up ⤷  Sign Up
Teikoku Pharma Usa LIDODERM lidocaine PATCH;TOPICAL 020612-001 Mar 19, 1999 ⤷  Sign Up ⤷  Sign Up
Teikoku Pharma Usa LIDODERM lidocaine PATCH;TOPICAL 020612-001 Mar 19, 1999 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for lidocaine

Country Patent Number Title Estimated Expiration
European Patent Office 3363432 TIMBRE NON AQUEUX (NON-AQUEOUS PATCH) ⤷  Sign Up
Mexico 368747 PARCHE NO ACUOSO DE LIDOCAÍNA Y UN AGENTE DE DISOLUCIÓN QUE COMPRENDE UN ÁCIDO ORGÁNICO Y UN POLIALCOHOL QUE ESTÁN CONTENIDOS EN UN EMPLASTE PARA USARSE EN EL TRATAMIENTO DE DOLOR MUSCULAR A TRAVÉS DE LA PIEL. (NON-AQUEOUS PATCH.) ⤷  Sign Up
Mexico 349572 PARCHE NO ACUOSO. (NON-AQUEOUS PATCH.) ⤷  Sign Up
Taiwan 201249431 Non-aqueous patch ⤷  Sign Up
Denmark 2823815 ⤷  Sign Up
Mexico 2014003688 PARCHE NO ACUOSO. (NON-AQUEOUS PATCH.) ⤷  Sign Up
Poland 2823815 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.